European Respiratory Society
banner
europeanrespsoc.bsky.social
European Respiratory Society
@europeanrespsoc.bsky.social
A non-profit organisation dedicated to sharing scientific knowledge, fighting lung disease and promoting lung health. ERS has more than 35,000 members worldwide. ersnet.org
Innovations in technology will revolutionise lung function assessment through three approaches: newer techniques (e.g. oscillometry), data acquisition through digital devices outside the clinic and data analysis through artificial intelligence tools. https://bit.ly/46qRf9C
November 23, 2025 at 5:38 PM
Reducing the use of oral corticosteroids (OCS) in severe asthma is now a key clinical objective; health economic modelling of OCS-sparing strategies indicates that early action would have a tangible, positive impact on the cost of OCS-related comorbidities https://bit.ly/3YBvfp9
November 23, 2025 at 2:07 PM
This article presents the pathophysiological mechanisms by which patients with pleural effusion experience dyspnoea and the mechanism by which these patients may clinically benefit from thoracentesis, regardless of the size of the pleural effusion. https://bit.ly/486GQC7
November 22, 2025 at 4:06 PM
ERJ Open Research: Increasing shift work frequency is more strongly related to asthma in females than in males https://bit.ly/4jfPml8
November 22, 2025 at 1:37 PM
Rigid bronchoscopy permits direct visualisation and intervention within the central airways, enabling complex therapeutic procedures, e.g. foreign body removal, tumour debulking, stent deployment, and in massive haemoptysis; general anaesthesia is mandated https://bit.ly/3KLVepN
November 21, 2025 at 4:11 PM
ERJOR: Airway NETs are increased in obese people with asthma, while NETs are also associated with BMI. Airway eDNA is associated with lower lung function and asthma control. NETs are likely source of eDNA as DNA–elastase complexes correlate with eDNA. https://bit.ly/43s0R3A
November 21, 2025 at 2:58 PM
At #COP11, ERS is coordinating with partners and observing negotiations to bring strong respiratory-health evidence into discussions, from environmental protections to safeguarding future generations 🌍🚭

Learn more about ERS #tobaccocontrol activities: https://bit.ly/3AvuHIV
November 20, 2025 at 6:30 PM
Breathe: Aspergillosis is often overlooked, but recognising it early in patients with chronic or recurrent lung infections can be life-changing. Lisa's experience shows why clinicians must consider aspergillosis. https://bit.ly/3WPqas3
November 20, 2025 at 5:14 PM
ERJ Open Research: Physiological variability measures significantly differ between stable and exacerbating groups of COPD patients. This can be used to build exacerbation detection algorithms in the future, leading to improved patient outcomes. https://bit.ly/4d2YMOC
November 20, 2025 at 4:10 PM
The latest Interactive Education, ‘Early diagnosis of ILD’, uses real-world clinical scenarios to bridge gaps in knowledge and enhance decision-making around early ILD and interstitial lung abnormalities (ILA), familial risk, genetic testing, and more.

Watch now: https://bit.ly/443ekP3
November 20, 2025 at 1:48 PM
Administrative health data are often used to assess guideline-concordance in COPD medication use, but definitions of guideline-concordance vary. This study reviewed these definitions, highlighting the utility of administrative data in analysing COPD care. https://bit.ly/4iz7nKa
November 19, 2025 at 5:35 PM
European Respiratory Journal: This multidisciplinary panel of lung cancer experts from different specialties has generated practical and up-to-date recommendations to assess patients’ fitness for curative intent treatment for lung cancer https://bit.ly/4m57e3s
November 19, 2025 at 4:10 PM
📄 ERS and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer has now been published in the European Respiratory Journal.

Access the guideline and all associated content via the ERS Respiratory Channel: https://bit.ly/4qW4GI5
November 19, 2025 at 11:26 AM
ERR: Several countries have recently updated their recommendations by including PCV20 in vaccination strategies for older adults and individuals at high risk for pneumococcal disease. PCV20 is safe, effective and believed to reduce healthcare costs. https://bit.ly/425aeVL
November 18, 2025 at 5:51 PM
ERJ Open Res: Novel electrochemical NO measurement during laryngeal mask ventilation showed promising repeatability and precision in screening for PCD in children <5 years. This may help diagnose PCD in young patients and simplify differential diagnostics. https://bit.ly/43kifHf
November 18, 2025 at 4:13 PM
More than 1,400 delegates from 162 Parties have gathered in Geneva this week for #COP11, the world’s main decision-making forum on tobacco control under the WHO Framework Convention on Tobacco Control.

Read the ERS statement to COP11: https://bit.ly/49IHozh

#lunghealth
November 18, 2025 at 10:16 AM
European Respiratory Review: Several gene mutations have been reported to cause early-onset emphysema with known Mendelian traits. Next-generation sequencing offers a promising method to understand early-onset emphysema and COPD pathogenesis. https://bit.ly/4695zEM
November 17, 2025 at 5:13 PM
ERJOR: Hospitalisations for bronchiectasis have unique socioeconomic and healthcare utilisation profiles, with worse outcomes than COPD and asthma. Outcomes for bronchiectasis overlap with COPD or asthma were no worse than those for bronchiectasis alone. https://bit.ly/3GVx2zk
November 17, 2025 at 3:45 PM
At #COP11, ERS urges governments to take decisive steps to end the tobacco epidemic and the pollution it leaves behind 🚭🌍

Learn more and read the ERS statement to COP11: https://bit.ly/3LJ1X4o

#Tobaccocontrol #Tobaccoendgame @whofctc.bsky.social
November 17, 2025 at 10:14 AM
Patients with severe asthma and blood eosinophil counts ≥150–<300 cells/μL showed reduced severe disease exacerbations and maintenance oral corticosteroid use with mepolizumab, whilst improving asthma control and lung function in routine clinical practice https://bit.ly/40dTdHR
November 15, 2025 at 4:08 PM
ERJ Open Research: A Chatbot-guided application provided educational content incorporating GINA guidelines and direct contact with pulmonology specialists. Compared with standard therapeutic education, its use was associated with improvements in QoL. https://bit.ly/4fzXWu8
November 15, 2025 at 1:15 PM
ERJ Open Research: Cough-variant asthma exhibits overlapping but distinct airway transcriptomic profiles compared to classic asthma. Two distinct inflammatory endotypes of cough-variant asthma are identified, presenting different clinical outcomes. https://bit.ly/3Zmgjvs
November 14, 2025 at 4:51 PM
Asthma or allergic asthma in the mother increases the risk of asthma in the child. Higher maternal lung function in pregnancy leads to a lower risk of asthma in the child. https://bit.ly/4cTSy3n
November 14, 2025 at 3:17 PM
European Respiratory Journal: FENO testing at attack can identify the patients on anti-IL5/IL5Rα biologics who have the most lung function and symptom benefits from prednisolone https://bit.ly/3KhMB68
November 14, 2025 at 1:49 PM
New Interactive Education video available: Early diagnosis of ILD!

Join Prof. Elisabetta Renzoni, Prof. Sara Tomasetti, and Dr Raphael Borie as they use real-world clinical scenarios to discuss critical gaps in knowledge.

Watch now on the ERS Respiratory Channel: https://bit.ly/443ekP3
November 14, 2025 at 12:59 PM